Wordt geladen...
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease
Huntington's disease (HD) is an autosomal dominant, neurodegenerative disorder characterized by motor as well as nonmotor symptoms for which there is currently no cure. The Q175 mouse model of HD recapitulates many of the symptoms identified in HD patients including disruptions of the sleep/wak...
Bewaard in:
| Gepubliceerd in: | Pharmacol Res Perspect |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5625154/ https://ncbi.nlm.nih.gov/pubmed/28971617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.344 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|